Edwards Lifesciences Sustainability Profile
Edwards Lifesciences Corporation, a leader in heart valve therapies and critical care monitoring, is headquartered in the United States. Founded in 1958, the company has established itself as a pioneer in the medical technology industry, particularly in the development of innovative solutions for patients with cardiovascular diseases. With a strong presence in North America, Europe, and Asia, Edwards Lifesciences focuses on advanced heart valve replacement and repair technologies, as well as haemodynamic monitoring systems. Their flagship products, including the transcatheter aortic valve replacement (TAVR) systems, are renowned for their unique design and effectiveness, significantly improving patient outcomes. Recognised for its commitment to innovation, Edwards Lifesciences has achieved numerous accolades, solidifying its position as a trusted name in the healthcare sector. The company continues to drive advancements in cardiac care, enhancing the quality of life for patients worldwide.
DitchCarbon Score
How does Edwards Lifesciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Edwards Lifesciences's score of 82 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Edwards Lifesciences's reported carbon emissions
In 2024, Edwards Lifesciences reported total greenhouse gas emissions of approximately 15,682,000 kg CO2e for Scope 1 and about 22,393,000 kg CO2e for Scope 2, resulting in combined Scope 1 and 2 emissions of around 38,075,000 kg CO2e. In 2023, the company disclosed Scope 1 emissions of about 16,120,000 kg CO2e, Scope 2 emissions of approximately 23,783,000 kg CO2e (market-based), and significant Scope 3 emissions totalling about 571,975,000 kg CO2e. Edwards Lifesciences has set ambitious climate commitments, aiming for carbon neutrality by 2030. This includes a target to reduce absolute Scope 1 and 2 emissions by 42% from a 2021 baseline. Additionally, the company plans to decrease upstream Scope 3 emissions by 51.6% per USD of value added within the same timeframe. These targets are aligned with the Science Based Targets initiative (SBTi) and reflect a commitment to transitioning to renewable energy sources for the majority of its global electricity demand. The company has also reported a commitment to enhance the efficiency of its operations, with a focus on renewable energy generation through both onsite and offsite methods. These initiatives underscore Edwards Lifesciences's dedication to reducing its carbon footprint and contributing to global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 4,977,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 23,498,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - |
How Carbon Intensive is Edwards Lifesciences's Industry?
How Carbon Intensive is Edwards Lifesciences's Location?
Edwards Lifesciences's Scope 3 Categories Breakdown
Edwards Lifesciences's Scope 3 emissions, which increased by 12% last year and increased significantly since 2015, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 72% of Scope 3 emissions.
Top Scope 3 Categories
Edwards Lifesciences's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Edwards Lifesciences has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Boston Scientific
Abiomed, Inc.
Frequently Asked Questions
Common questions about Edwards Lifesciences's sustainability data and climate commitments